Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Assets Average (2018 - 2025)

Historic Assets Average for Arcus Biosciences (RCUS) over the last 8 years, with Q3 2025 value amounting to $1.0 billion.

  • Arcus Biosciences' Assets Average fell 1804.0% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year decrease of 1804.0%. This contributed to the annual value of $1.1 billion for FY2024, which is 626.3% down from last year.
  • Arcus Biosciences' Assets Average amounted to $1.0 billion in Q3 2025, which was down 1804.0% from $1.1 billion recorded in Q2 2025.
  • Arcus Biosciences' 5-year Assets Average high stood at $1.6 billion for Q1 2022, and its period low was $853.7 million during Q1 2021.
  • In the last 5 years, Arcus Biosciences' Assets Average had a median value of $1.2 billion in 2021 and averaged $1.2 billion.
  • As far as peak fluctuations go, Arcus Biosciences' Assets Average skyrocketed by 35020.25% in 2021, and later tumbled by 1854.38% in 2023.
  • Arcus Biosciences' Assets Average (Quarter) stood at $1.2 billion in 2021, then increased by 10.8% to $1.3 billion in 2022, then decreased by 15.14% to $1.1 billion in 2023, then rose by 7.17% to $1.2 billion in 2024, then fell by 16.37% to $1.0 billion in 2025.
  • Its Assets Average stands at $1.0 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.2 billion for Q1 2025.